Elli Peselev

Array ( [id] => 1093093 [patent_doc_number] => 06825170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => '6-O-acyl ketolide antibacterials' [patent_app_type] => B2 [patent_app_number] => 10/301412 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51905 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 1420 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825170.pdf [firstpage_image] =>[orig_patent_app_number] => 10301412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641832 [patent_doc_number] => 07122525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Targeted therapeutics and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/302409 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 15475 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122525.pdf [firstpage_image] =>[orig_patent_app_number] => 10302409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788111 [patent_doc_number] => 20030139350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents' [patent_app_type] => new [patent_app_number] => 10/300831 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7325 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139350.pdf [firstpage_image] =>[orig_patent_app_number] => 10300831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1217251 [patent_doc_number] => 06706865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Process for preparing flavonoids' [patent_app_type] => B2 [patent_app_number] => 10/220202 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5832 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706865.pdf [firstpage_image] =>[orig_patent_app_number] => 10220202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766342 [patent_doc_number] => 20030100742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Erythromycin a derivatives' [patent_app_type] => new [patent_app_number] => 10/300947 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9384 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100742.pdf [firstpage_image] =>[orig_patent_app_number] => 10300947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801863 [patent_doc_number] => 20030097028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method for preparing a composition containing at least one internal dehydration product for a hydrogenated sugar' [patent_app_type] => new [patent_app_number] => 10/299138 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7451 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20030097028.pdf [firstpage_image] =>[orig_patent_app_number] => 10299138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710573 [patent_doc_number] => 20030170322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Throat care agents' [patent_app_type] => new [patent_app_number] => 10/275956 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5503 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170322.pdf [firstpage_image] =>[orig_patent_app_number] => 10275956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730710 [patent_doc_number] => 20030186900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus' [patent_app_type] => new [patent_app_number] => 10/294587 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14097 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186900.pdf [firstpage_image] =>[orig_patent_app_number] => 10294587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237702 [patent_doc_number] => 20050080025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Macrolides' [patent_app_type] => utility [patent_app_number] => 10/495413 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38628 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080025.pdf [firstpage_image] =>[orig_patent_app_number] => 10495413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706797 [patent_doc_number] => 20030153531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Modified polysaccharides exhibiting altered biological recognition' [patent_app_type] => new [patent_app_number] => 10/293910 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10002 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153531.pdf [firstpage_image] =>[orig_patent_app_number] => 10293910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 579254 [patent_doc_number] => 07456276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Peptide purification by means of metal ion affinity chromatography' [patent_app_type] => utility [patent_app_number] => 10/495302 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 54397 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456276.pdf [firstpage_image] =>[orig_patent_app_number] => 10495302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658308 [patent_doc_number] => 07105491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Biosynthesis of enediyne compounds by manipulation of C-1027 gene pathway' [patent_app_type] => utility [patent_app_number] => 10/292198 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 37 [patent_no_of_words] => 31316 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105491.pdf [firstpage_image] =>[orig_patent_app_number] => 10292198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163063 [patent_doc_number] => 20050085413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Dimeric pharmaceutical compounds and their use' [patent_app_type] => utility [patent_app_number] => 10/494942 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13159 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085413.pdf [firstpage_image] =>[orig_patent_app_number] => 10494942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 654775 [patent_doc_number] => 07109175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-19 [patent_title] => 'Specific steady-state R-type CA2+ channel blockers and use thereof' [patent_app_type] => utility [patent_app_number] => 10/291852 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 109 [patent_no_of_words] => 20697 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109175.pdf [firstpage_image] =>[orig_patent_app_number] => 10291852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104676 [patent_doc_number] => 06812037 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'Antimitotic compounds' [patent_app_type] => B1 [patent_app_number] => 10/148017 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7223 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812037.pdf [firstpage_image] =>[orig_patent_app_number] => 10148017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739856 [patent_doc_number] => 20030157225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Food product and process' [patent_app_type] => new [patent_app_number] => 10/181549 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7147 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157225.pdf [firstpage_image] =>[orig_patent_app_number] => 10181549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 731572 [patent_doc_number] => 07037523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Controlled release compositions for macrolide antimicrobial agents' [patent_app_type] => utility [patent_app_number] => 10/286389 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4459 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037523.pdf [firstpage_image] =>[orig_patent_app_number] => 10286389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318718 [patent_doc_number] => 07521428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Macrolide derivatives having effect of potentiating antifungal activity' [patent_app_type] => utility [patent_app_number] => 10/472044 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9624 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521428.pdf [firstpage_image] =>[orig_patent_app_number] => 10472044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6703335 [patent_doc_number] => 20030150069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Use of sugar surfactants and fatty acid partial glycerides' [patent_app_type] => new [patent_app_number] => 10/281578 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14945 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20030150069.pdf [firstpage_image] =>[orig_patent_app_number] => 10281578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 560951 [patent_doc_number] => 07157575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Substrates for β-lactamase and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/280482 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 21442 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157575.pdf [firstpage_image] =>[orig_patent_app_number] => 10280482 [rel_patent_id] =>[rel_patent_doc_number] =>)